Literature DB >> 17562832

Connective tissue and vascular phenotype in patients with cervical artery dissection.

R Dittrich1, A Heidbreder, D Rohsbach, J Schmalhorst, I Nassenstein, D Maintz, E B Ringelstein, D G Nabavi, G Kuhlenbäumer.   

Abstract

BACKGROUND: Clinical observations and electron microscopic investigation of skin biopsies demonstrated connective tissue abnormalities in a sizeable proportion of patients with spontaneous cervical artery dissection (sCAD), suggesting an unknown connective tissue disorder as a risk factor for sCAD.
OBJECTIVE: To evaluate in a case-control setting if patients with sCAD exhibit clinical signs indicative of a connective tissue disorder or show a vascular phenotype.
METHODS: We investigated 43 consecutive patients with sCAD and 43 consecutive patients of similar age with ischemic stroke of other etiology. All patients underwent standardized MRI of the head and neck. The clinical investigation contained 25 items characteristic for connective tissue diseases such as hyperextensible skin, articular hypermobility, capillary fragility, and facial stigmata. A sum score counting all positive items was calculated. Additionally, the diameter of the common carotid artery (CCA) and vertebral artery (VA) and heart valve pathologies were assessed.
RESULTS: Connective tissue sum scores did not differ between the sCAD group (mean 2.37 +/- 2.1, median 2) and the control group (mean 1.95 +/- 1.9, median 2, p = 0.34). One sCAD patient had osteogenesis imperfecta (2.3%) and exhibited the highest sum score of 8. The diameter of the CCA and VA and the prevalence of heart valve pathologies did not show any significant differences between groups.
CONCLUSION: The connective tissue and vascular phenotype did not differ significantly between patients with spontaneous cervical artery dissection (sCAD) and control subjects with ischemic stroke of other etiology. These findings argue against a clinically apparent connective tissue disorder underlying sCAD. The prevalence of known connective tissue diseases in sCAD patients is low.

Entities:  

Mesh:

Year:  2007        PMID: 17562832     DOI: 10.1212/01.wnl.0000264892.92538.a9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Arterial elongation ("redundancy") is not a feature of spontaneous cervical artery dissection.

Authors:  Ralf Dittrich; Isabelle Nassenstein; Siri Harms; David Maintz; Walter Heindel; Gregor Kuhlenbäumer; Erich Bernd Ringelstein
Journal:  J Neurol       Date:  2010-09-10       Impact factor: 4.849

2.  Cervical Artery Dissection: A Review of the Epidemiology, Pathophysiology, Treatment, and Outcome.

Authors:  Christina A Blum; Shadi Yaghi
Journal:  Arch Neurosci       Date:  2015-10-17

3.  Internal carotid artery dissection, cerebral aneurysms and thin basement membrane nephropathy.

Authors:  Nicholas J Cutfield; John L Wilson; L Jonathan Zwi; Barry J Snow
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

Review 4.  Clinical characteristics of symptomatic vertebral artery dissection: a systematic review.

Authors:  Rebecca F Gottesman; Priti Sharma; Karen A Robinson; Martinson Arnan; Megan Tsui; Karim Ladha; David E Newman-Toker
Journal:  Neurologist       Date:  2012-09       Impact factor: 1.398

5.  Connective tissue anomalies in patients with spontaneous cervical artery dissection.

Authors:  Alessia Giossi; Marco Ritelli; Paolo Costa; Andrea Morotti; Loris Poli; Elisabetta Del Zotto; Irene Volonghi; Nicola Chiarelli; Massimo Gamba; Paolo Bovi; Giampaolo Tomelleri; Monica Carletti; Nicoletta Checcarelli; Giorgio Meneghetti; Michele Morra; Mauro Chinaglia; Valeria De Giuli; Marina Colombi; Alessandro Padovani; Alessandro Pezzini
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

6.  Risk factors and clinical presentation of craniocervical arterial dissection: a prospective study.

Authors:  Lucy C Thomas; Darren A Rivett; John R Attia; Christopher R Levi
Journal:  BMC Musculoskelet Disord       Date:  2012-09-03       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.